Previous Article | Next Article ![]()
J. Virol., 07 1997, 5209-5217, Vol 71, No. 7
R Welker, A Janetzko and HG Krausslich
Retrovirus morphogenesis involves assembly of structural Gag polyproteins
with subsequent budding from the plasma membrane, followed by proteolytic
cleavage by the viral proteinase (PR) and extracellular maturation to the
infectious virion. Intracisternal A-type particles (IAPs) are defective
retroviruses that assemble and bud at the membranes of the endoplasmic
reticulum (ER), where they remain as immature particles consisting
exclusively of uncleaved polyproteins. To analyze requirements for
intracellular polyprotein transport and PR activation, we constructed
deletion and substitution mutations in the IAP gag gene, including the
putative ER-targeting signal. Mutant polyproteins were transported to
various intracellular locations, including the nucleus, the cytoplasm, the
ER, and the plasma membrane. Interestingly, assembly of capsid-like
particle structures occurred at almost all sites. However, only those
polyproteins transported to the plasma membrane were efficiently and
specifically cleaved by viral PR, with cleavage occurring predominantly
within the virus particle. Thus, at least in the experimental system
presented here, retroviral particle assembly can occur at almost any
location within the cell, while polyprotein processing and, consequently,
virion maturation are confined to a specific cellular site. These results
suggest that a factor restricted to the plasma membrane is required to
trigger PR activation and maturation of infectious retroviruses.
Copyright © 1997, American Society for Microbiology
Plasma membrane targeting of chimeric intracisternal A-type particle polyproteins leads to particle release and specific activation of the viral proteinase
Heinrich-Pette-Institut fur experimentelle Virologie und Immunologie an der Universitat Hamburg, Germany.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|